Skip to main content

Diagnostic options Β· UAE

Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 106–120 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4540
GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 (HHT5) Genetic Test

This test evaluates the GDF2 gene for mutations associated with Hereditary Hemorrhagic Telangiectasia Type 5 (HHT5), a rare vascular disorder.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GDF2 gene pathogenic variants", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"]
Parameters
[]
Preparation
["Inform phlebotomist if on anticoagulant therapy", "No other special preparation needed"]
Indications
["Diagnosis of HHT5 in symptomatic individuals", "Predictive testing in at-risk family members", "Cascade screening of affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: I78.0
Clinical summary
This test evaluates the GDF2 gene for mutations associated with Hereditary Hemorrhagic Telangiectasia Type 5 (HHT5), a rare vascular disorder.
TEST-3027
GDF5 Gene Brachydactyly Type A1C Genetic Test

This test identifies pathogenic variants in the GDF5 gene associated with isolated brachydactyly type A1C.

Peripheral whole blood (3–5 mL in EDTA) or dried blood spot (FTA card) 3–4 weeks from sample receipt and genetic counselling 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GDF5 gene", "Coding region and splice sites of GDF5"]
Parameters
[]
Preparation
[]
Indications
["Suspected isolated brachydactyly type A1C", "Family history of brachydactyly type A1C"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q74.0
Clinical summary
This test identifies pathogenic variants in the GDF5 gene associated with isolated brachydactyly type A1C.
TEST-4753
GFI1 Gene Genetic Test for Nonimmune Chronic Idiopathic Neutropenia of Adults (NI-CINA)

This test evaluates the GFI1 gene for pathogenic variants associated with nonimmune chronic idiopathic neutropenia in adults.

Whole blood (EDTA tube) or buccal swab 3 to 4 Weeks from sample receipt at laboratory 2,800.00 AED
View
View test specifications and preparation
What it measures
["GFI1 gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session", "Document three-generation pedigree"]
Indications
["Diagnosis of nonimmune chronic idiopathic neutropenia (NI-CINA)", "Family history of neutropenia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81305-5 ICD-10: D70.0
Clinical summary
This test evaluates the GFI1 gene for pathogenic variants associated with nonimmune chronic idiopathic neutropenia in adults.
TEST-4766
GFI1 Gene Severe Congenital Neutropenia Type 2 (Autosomal Dominant) Genetic Test

This test identifies mutations in the GFI1 gene associated with Severe Congenital Neutropenia Type 2.

Whole blood (EDTA), Extracted DNA (β‰₯2 ΞΌg), or Dried Blood Spot (FTA card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GFI1 gene sequence", "Pathogenic variants"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Detailed pedigree chart of family members required"]
Indications
["Infants, children, or adults presenting with recurrent, life-threatening infections", "Unexplained persistent neutropenia", "Documented family history suggestive of congenital neutropenia", "Evaluation for bone marrow failure syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D70.0
Clinical summary
This test identifies mutations in the GFI1 gene associated with Severe Congenital Neutropenia Type 2.
TEST-2496
GJA1 Gene Oculodentodigital Dysplasia Genetic Test

This test evaluates the GJA1 gene for pathogenic variants associated with Oculodentodigital Dysplasia (ODDD). It identifies mutations causing microphthalmia, dental enamel hypoplas...

Peripheral whole blood, dried blood spot (FTA card), or isolated DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJA1 gene coding regions", "Pathogenic variants (missense, nonsense, splice-site, small insertions/deletions)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Suspected Oculodentodigital Dysplasia (ODDD)", "Family history of ODDD", "Need for genetic counseling regarding ODDD"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82328-0 ICD-10: Q87.8
Clinical summary
This test evaluates the GJA1 gene for pathogenic variants associated with Oculodentodigital Dysplasia (ODDD). It identifies mutations causing microphthalmia, dental enamel hypoplasia, and syndactyly.
TEST-5931
GLB1 Gene Mucopolysaccharidosis Type 4B Genetic Test

This genetic test evaluates the GLB1 gene for pathogenic variants associated with Mucopolysaccharidosis type IVB (Morquio syndrome B). It identifies single-nucleotide variants and...

Whole blood (EDTA) – 3–5 mL; also accepts extracted DNA or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLB1 gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Symptomatic patients with clinical suspicion of Morquio syndrome B", "Carrier testing in at-risk relatives", "Prenatal diagnosis after genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21615-0 ICD-10: E76.22
Clinical summary
This genetic test evaluates the GLB1 gene for pathogenic variants associated with Mucopolysaccharidosis type IVB (Morquio syndrome B). It identifies single-nucleotide variants and small insertions/deletions.
TEST-2655
GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the GLE1 gene associated with Lethal Congenital Contracture Syndrome Type 1 (LCCS1). It confirms the molecular basis for this severe aut...

Whole Blood (EDTA), Extracted DNA, Dried Blood Spot on FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLE1 gene", "Homozygous or compound heterozygous variants"]
Parameters
[]
Preparation
["A clinical history review is mandatory", "A formal genetic counselling session to document a family pedigree is mandatory"]
Indications
["Neonates with arthrogryposis and pulmonary hypoplasia", "Carrier screening in couples with a positive family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55115-1 ICD-10: Q68.8
Clinical summary
This test identifies pathogenic variants in the GLE1 gene associated with Lethal Congenital Contracture Syndrome Type 1 (LCCS1). It confirms the molecular basis for this severe autosomal recessive disorder.
TEST-3508
GNAS Gene Pseudohypoparathyroidism Type 1C Genetic Test

This test identifies pathogenic variants within the GNAS gene associated with Pseudohypoparathyroidism Type 1C.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNAS gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid recent whole-blood transfusion (within 2 weeks)"]
Indications
["Suspected Pseudohypoparathyroidism Type 1C", "Need for definitive molecular diagnosis", "Familial screening for PHP-1C"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48783-2 ICD-10: E20.1
Clinical summary
This test identifies pathogenic variants within the GNAS gene associated with Pseudohypoparathyroidism Type 1C.
TEST-2404
GNPAT Gene Rhizomelic Chondrodysplasia Punctata Type 2 Genetic Test

This test analyzes the GNPAT gene for mutations associated with rhizomelic chondrodysplasia punctata type 2.

Peripheral Whole Blood (5–10 mL) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GNPAT gene mutations", "Peroxisomal disorder genetic markers"]
Parameters
[]
Preparation
["Consult the ordering physician if the patient has an acute infection or recent steroid therapy."]
Indications
["Clinical suspicion of rhizomelic chondrodysplasia punctata type 2", "Family history of peroxisomal disorders", "Need for genetic confirmation for diagnosis and management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 104199-9 ICD-10: Q77.3
Clinical summary
This test analyzes the GNPAT gene for mutations associated with rhizomelic chondrodysplasia punctata type 2.
TEST-6005
GNPTAB Gene Mucolipidosis Type II Alpha/Beta Genetic Test

This diagnostic test evaluates the entire GNPTAB gene for pathogenic variants associated with Mucolipidosis II (I-cell disease). It utilizes next-generation sequencing (NGS) with c...

Peripheral Whole Blood (EDTA) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNPTAB gene", "Copy Number Variations (CNVs) within the GNPTAB gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected diagnosis of Mucolipidosis II (I-cell disease)", "Family history of Mucolipidosis II", "Carrier screening in at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82310-1 ICD-10: E77.0
Clinical summary
This diagnostic test evaluates the entire GNPTAB gene for pathogenic variants associated with Mucolipidosis II (I-cell disease). It utilizes next-generation sequencing (NGS) with copy number variation (CNV) detection.
TEST-4033
GP1BA Gene Bernard-Soulier Syndrome Type A2 Genetic Test

This test identifies genetic variants in the GP1BA gene associated with Bernard-Soulier syndrome type A2.

Peripheral whole blood (EDTA) or FTA card (buccal-derived DNA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GP1BA gene sequence", "Single-nucleotide variants", "Insertions/deletions", "Exon-level copy number changes"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of Bernard-Soulier syndrome type A2", "Family cascade screening", "Pre-implantation genetic planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D69.1
Clinical summary
This test identifies genetic variants in the GP1BA gene associated with Bernard-Soulier syndrome type A2.
TEST-3983
GUCY1A3 Gene NGS Test for Moyamoya Typeβ€―6 with Achalasia

This diagnostic test evaluates the GUCY1A3 gene for pathogenic variants associated with Moyamoya disease type 6 and achalasia.

Peripheral whole blood, extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GUCY1A3 gene", "Genetic predisposition to Moyamoya disease type 6", "Genetic predisposition to Achalasia"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"]
Indications
["Suspected Moyamoya disease type 6", "Suspected Achalasia", "Family history of Moyamoya disease or Achalasia", "Need for genetic confirmation for management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90509-0 ICD-10: I67.5, K22.0
Clinical summary
This diagnostic test evaluates the GUCY1A3 gene for pathogenic variants associated with Moyamoya disease type 6 and achalasia.
TEST-6386
GYS2 Gene Glycogen Storage Disease Type 0 (GSD 0) Genetic Test

This test identifies pathogenic variants within the GYS2 gene associated with Glycogen Storage Disease Type 0 (GSD 0). It utilizes Next-Generation Sequencing (NGS) for comprehensiv...

Whole Blood, Extracted DNA, or One Drop Blood on FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GYS2 gene", "Coverage of intron-exon boundaries"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your physician", "Pre-test genetic counseling is mandatory"]
Indications
["Suspected Glycogen Storage Disease Type 0 (GSD 0)", "Family history of GSD 0"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101521-1 ICD-10: E74.09, Z15.81, Z13.228
Clinical summary
This test identifies pathogenic variants within the GYS2 gene associated with Glycogen Storage Disease Type 0 (GSD 0). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-1547
Hemochromatosis HFE Full Gene Sequence Analysis Test

This test evaluates the HFE gene for mutations associated with hereditary hemochromatosis.

Peripheral whole blood 4–6 business weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["HFE gene sequence", "Pathogenic variants (e.g., C282Y, H63D, S65C)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions (within 4 weeks)"]
Indications
["Suspected hereditary hemochromatosis", "Elevated iron studies", "Family history of hemochromatosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94217-3 ICD-10: E83.110
Clinical summary
This test evaluates the HFE gene for mutations associated with hereditary hemochromatosis.
TEST-4869
HERC2 Gene Mental Retardation, Autosomal Recessive Type 38 Test

This test analyzes the HERC2 gene to diagnose autosomal recessive mental retardation type 38 (MRT38). It detects pathogenic variants, including single-nucleotide variants, small in...

Peripheral whole blood or DNA specimen 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HERC2 gene", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current medications"]
Indications
["Diagnosis of autosomal recessive mental retardation type 38", "Recurrence risk counseling for families with affected individuals", "Carrier screening in families with a history of MRT38"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81267-6 ICD-10: F78
Clinical summary
This test analyzes the HERC2 gene to diagnose autosomal recessive mental retardation type 38 (MRT38). It detects pathogenic variants, including single-nucleotide variants, small insertions/deletions, and copy-number changes.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requiresβ€”book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.